サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1411403

医療美容の世界市場 (提供製品・機器の種類別、処置の種類別、エンドユーザー別、ジェンダー別、流通チャネル別、主要地域別)：産業動向と予測

Medical Aesthetics Market - Distribution by Type of Product and / or Device Offered, Type of Procedure, End User, Gender, Distribution Channel, and Key Geographical Regions : Industry Trends and Global Forecasts
出版日: | 発行: Roots Analysis | ページ情報: 英文 294 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
医療美容の世界市場 (提供製品・機器の種類別、処置の種類別、エンドユーザー別、ジェンダー別、流通チャネル別、主要地域別)：産業動向と予測
出版日: 2024年01月07日
発行: Roots Analysis
ページ情報: 英文 294 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

医療美容の世界市場は、2023年に350億米ドルと評価され、予測期間中 (2023～2035年) に9.3%のCAGRで成長します。

近年の医療美容ソリューションに対する需要の高まりは、若々しい外見を維持したいという願望、ソーシャルメディアの影響、技術進歩、有名人の支持、美容師や医療専門家の支持など、さまざまな要因によるものと考えられます。COVID-19のパンデミックも、美容治療の年間処置件数の増加に大きく寄与しています。国際美容整形外科学会 (ISAPS) が行った調査によると、2022年には世界中で1,500万件以上の侵襲的美容整形手術と、1,900万件以上の非侵襲的美容整形手術が行われています。業界の顧客の90%近くが女性ですが、男性の間でも美容医療の人気が高まっています。男性向け美容市場の成長の背景には、自然な仕上がりへの願望、低侵襲手術、外見への意識の高まりなど、女性向け美容市場の成長をもたらしたものと同じ傾向があります。

こうした処置に対する需要の高さから、医療美容の関連企業は医療用製品・機器を開発してきました。医療美容企業の主な関心事項は、非外科的または低侵襲のソリューションの開発にあります。最も一般的な低侵襲治療には、ボツリヌス毒素と美容用充填剤があります。これらの治療は主に、法令線の改善や皮膚の引き締めに用いられます。しかし、美容治療の利点は美容面に限らず、その他の一般的な医療上の問題の解決にも役立ちます。ボツリヌス毒素は、発汗や偏頭痛を抑えるために使われます。体の輪郭を整える機器、レーザー脱毛、タトゥー除去、爪の治療などは、外科手術以外の一般的な治療法の一部です。輪郭矯正器具は、皮膚を引き締め、脂肪を減らし、セルライトを減らすために使用されます。

医療美容治療は、医療美容クリニックや医療スパで受けることができます。現在の医療美容市場の70%以上が、病院、クリニック、医療スパによって運営されています。さらに、世界の整形外科の中心地である韓国は、国民一人当たりの美容整形手術件数が最も多い国です。これは、確立された美容外科インフラと、韓国への美容医療ツーリズムを奨励する熟練した医療専門家のおかげです。主な懸念事項として、一部の医療専門家と医療美容会社が規制ガイドラインに違反しており、副作用につながる可能性があります。こうした課題を克服し、医療美容サービスに対する需要の増加に対応することで、医療美容関連企業は今後数年間で飛躍的な成長を遂げると予測されます。

当レポートでは、世界の医療美容市場について分析し、処置の概要や市場の基本構造・最新情勢、主な市場促進・抑制要因、全体的な市場規模の動向見通し、セグメント別・地域別 (全5地域) の詳細動向、昨今の主な事業提携・資本取引の動き (投資、M&Aなど)、現在の競合情勢、主要企業のプロファイルなどを調査しております。

主な市場区分

提供製品・機器の種類別

  • ボツリヌス毒素
  • 皮膚充填剤
  • ケミカルピーリング
  • 輪郭形成
  • 臀部インプラント
  • 脱毛
  • 乳房インプラント
  • その他の製品/機器

処置の種類別

  • 非侵襲的
  • 低侵襲的
  • 侵襲的

エンドユーザー

  • 病院
  • クリニック/医療スパ、皮膚/美容センター
  • その他のエンドユーザー

ジェンダー別

  • 男性
  • 女性

販売チャネル別

  • 直接販売
  • 間接販売

主要地域別

  • 北米
  • 欧州
  • アジア太平洋
  • 中東・北アフリカ
  • ラテンアメリカ

当レポートでは、

主な市場参入企業

  • ADSS
  • Allergan Aesthetics
  • Astiland, Beijing Kes Biological Technology
  • BTL Aesthetics
  • Candela Medical
  • Classys
  • Croma Pharma
  • Cynosure
  • Daeyang Medical
  • Establishment Labs
  • Galderma
  • Guangzhou Itech Aesthetics
  • IBSA
  • Lumenis
  • Lutronic
  • MedicalZone
  • Mentor
  • Sanhe Medical
  • Shanghai Haohai Biological Technology
  • Sinclair Pharma
  • Sincoheren
  • Skin Tech Pharma
  • Wontech
  • Zesay Beauty

目次

第1章 序論

第2章 調査手法

第3章 景気動向・その他のプロジェクト特有の考慮事項

第4章 エグゼクティブサマリー

第5章 イントロダクション

  • 医療美容の概念
  • 医療美容の進化
  • 医療美容の種類
  • 医療美容のメリット
  • 医療美容の副作用
  • 主な成長促進要因
  • 医療美容における最新技術
  • 医療美容の主な課題
  • 将来展望

第6章 市場情勢

  • 医療美容企業：市場情勢

第7章 企業プロファイル

  • 主要企業のプロファイル
  • その他の企業の概略

第8章 企業競争力の分析

  • 主な前提条件とパラメーター
  • 調査手法
  • 医療美容：企業競争力の分析

第9章 パートナーシップとコラボレーション

  • パートナーシップモデル
  • 医療美容：パートナーシップとコラボレーション
  • 地域別の分析

第10章 資金調達と投資

  • 資金調達モデル
  • 医療美容：資金調達と投資
  • 結論

第11章 DELT分析

  • 調査手法
  • 主要なパラメーター
  • 医療美容：DELT分析
  • 結論

第12章 市場への影響分析：促進要因・抑制要因・機会・課題

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の課題
  • 結論

第13章 世界の医療美容市場

  • 主な前提条件と調査手法
  • 世界の医療美容市場：過去の動向 (2018～2022年) と今後の予測 (2023～2035年)
  • 主な市場区分
  • ダイナミックダッシュボード

第14章 医療美容市場：提供製品/デバイスの種類別

  • 主な前提条件と調査手法
  • 医療美容市場：提供製品/デバイスの種類別 (2018年、2023年、2035年)
  • データの計測と検証

第15章 医療美容市場：処置の種類別

  • 主な前提条件と調査手法
  • 医療美容市場：処置の種類別 (2018年、2023年、2035年)
  • データの計測と検証

第16章 医療美容市場：エンドユーザー別

  • 主な前提条件と調査手法
  • 医療美容市場：エンドユーザー別 (2018年、2023年、2035年)
  • データの計測と検証

第17章 医療美容市場：ジェンダー別

  • 主な前提条件と調査手法
  • 医療美容市場：ジェンダー別 (2018年、2023年、2035年)
  • データの計測と検証

第18章 医療美容市場：流通チャネル別

  • 主な前提条件と調査手法
  • 医療美容市場：流通チャネル別 (2018年、2023年、2035年)
  • データの計測と検証

第19章 医療美容市場：主要地域別

  • 主な前提条件と調査手法
  • 医療美容市場：主要地域別 (2018年、2023年、2035年)
  • データの計測と検証

第20章 医療美容製品の市場

  • 主な前提条件と調査手法
  • 世界の医療美容製品市場：過去の動向 (2018～2022年) と今後の予測 (2023～2035年)
  • データの計測と検証

第21章 経営陣の洞察

第22章 結論

第23章 付録1：表形式のデータ

第24章 付録2：企業・組織の一覧

目次
Product Code: RA100467

The medical aesthetics market is valued at USD 35 billion in 2023 growing at a CAGR of 9.3% during the forecast period 2023-2035.

The growing demand for medical aesthetic solutions in recent years can be attributed to various factors, including the desire to maintain a youthful appearance, the influence of social media, technological advancements, celebrity endorsements, and the support of beauticians and medical professionals. The COVID pandemic has also contributed significantly towards the increased number of annual aesthetic treatments. Medical aesthetics is a well-established branch of modern medicine that primarily focuses on enhancing the cosmetic appearance of an individual without clinical surgery. These treatments are mainly used for anti-aging purposes by reducing fine lines and wrinkles, lifting flabby skin, and skin rejuvenation. Medical aesthetic procedures can also help in reducing excess fat and cellulite, unwanted hair, and spider veins. According to a study conducted by the International Society of Aesthetic Plastic Surgery (ISAPS), over 15 million invasive aesthetic procedures and 19 million non-invasive aesthetic procedures have been performed globally in 2022. It is worth mentioning that nearly 90% of the industry clientele are women, however, these aesthetic procedures are also gaining popularity among men. In fact, men have shown an increased interest in the majority of major surgical and nonsurgical procedures, with the top cosmetic surgical procedures for men being rhinoplasty, eyelid surgery, cheek implant, breast reduction, liposuction, tummy tuck, and ear surgery. The reasons behind the growth of the male aesthetic market tend to be the same as those that have led to the growth of the female aesthetic market, including the desire for natural-looking results, minimally invasive procedures, and increased awareness of appearance.

Due to the high demand for these procedures, medical aesthetics companies have developed medical aesthetics products & devices. The main focus of medical aesthetics companies is to develop non-surgical or minimally invasive solutions. The majority of these treatments don't require a full surgical procedure. This means less pain and discomfort, fewer risks, shorter hospital stays, and long-lasting results. Some of the most common minimally invasive treatments are Botulism toxins and aesthetic filler. These treatments are mainly used for improving glabellar lines and tightening the skin. However, the advantages of aesthetic treatments aren't only cosmetic. They also help in solving other common healthcare problems. Botulism toxin is used to control sweating and migraines. Body contouring devices, laser hair removal, tattoo removal, and nail treatments are some of the other common non-surgical treatments. Body contouring devices are used for tightening the skin, reducing fat, and reducing cellulite.

Medical aesthetics treatments can be performed at a medical aesthetic clinic or at a medical spa. Dermatologists, plastic surgeons, doctors, nurse practitioners, registered nurses and aestheticians are among the medical professionals who can provide medical aesthetics treatments. It is interesting to note that more than 70% of the present medical aesthetics market is managed by hospitals, clinics and medical spas. In addition, South Korea, the plastic surgery capital in the world, is the country with the highest cosmetic surgeries per capita. This is because of the well-established cosmetic surgery infrastructure and the skilled medical professionals who encourage aesthetics medical tourism to South Korea. The main concern is that some medical professionals and the medical aesthetics companies are violating the regulatory guidelines, which can lead to side-effects. Therefore, it is extremely important for the patient to undergo medical aesthetics treatment by a licensed medical professional, using certified aesthetic devices, to avoid any such risks and complications. By overcoming these obstacles and meeting the increasing demand for medical aesthetics services, medical aesthetics companies are projected to see tremendous growth in the coming years.

Key Market Segments

Type of Product and / or Device Offered

  • Botulinum Toxin
  • Dermal Fillers
  • Chemical Peels
  • Body Contouring
  • Gluteal Implants
  • Hair Removal
  • Breast Implants
  • Other Products / Devices

Type of Procedure

  • Non Invasive
  • Minimally Invasive
  • Invasive

End User

  • Hospitals
  • Clincs / Med Spas and Dermatology / Cosmetology Centers
  • Other end users

Gender

  • Male
  • Female

Distribution Channel

  • Direct Distribution
  • Indirect Distribution

Key Geographical Regions

  • North America
  • Europe
  • Asia-Pacific
  • Middle East and North Africa
  • Latin America

Research Coverage:

The report studies the medical aesthetics market based on type of product and / or device offered, type of procedure, end user, gender, distribution channel, and key geographical regions

The report assesses the potential advantages and obstacles within the market for those involved and offers information on the competitive environment for top players in the market.

The report forecasts the revenue of market segments with respect to five major regions

The report provides an overview of medical aesthetics, including its evolution, types, and application areas. It also covers the benefits of these procedures compared to traditional beauty treatments and the side effects associated with them. The chapter also covers the key drivers of growth, new technologies, key issues and future prospects in this field.

Comprehensive analysis of the current landscape of medical aesthetics developers considering parameters such as establishment year, company size, headquarters, type of offering (product and / or device), type of products and / or devices offered, application area, type of procedure and end user

In-depth profiles of companies offering medical aesthetic procedures products and / or devices, focusing on company overviews, financial information (where available), offered medical aesthetic procedures, recent advancements, and informed future prospects.

Detailed company competitiveness evaluation of medical aesthetics company, considering supplier strength in terms of type of offering, type of product and / or device offered and type of procedure, and number of end users served.

An analysis of partnerships established in this sector since 2018, covering merger and acquisition, distribution, commercialization, licensing, supply, product development, product and technology integration and manufacturing agreements.

A comprehensive examination of funding and investments made in medical aesthetics companies since 2018, encompassing venture capital financing, secondary offerings, private placements, grants, debt financing, and other equity.

The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.

Key Benefits of Buying this Report

  • The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
  • Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
  • The report provides stakeholders with a pulse on the medical aesthetics market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Key Market Companies

  • ADSS
  • Allergan Aesthetics
  • Astiland, Beijing Kes Biological Technology
  • BTL Aesthetics
  • Candela Medical
  • Classys
  • Croma Pharma
  • Cynosure
  • Daeyang Medical
  • Establishment Labs
  • Galderma
  • Guangzhou Itech Aesthetics
  • IBSA
  • Lumenis
  • Lutronic
  • MedicalZone
  • Mentor
  • Sanhe Medical
  • Shanghai Haohai Biological Technology
  • Sinclair Pharma
  • Sincoheren
  • Skin Tech Pharma
  • Wontech
  • Zesay Beauty

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Introduction
  • 1.2. Project Objectives
  • 1.3. Scope of the Report
  • 1.4. Research Methodology
  • 1.5. Frequently Asked Questions
  • 1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

  • 2.1. Chapter Overview
  • 2.2. Research Assumptions
  • 2.3. Project Methodology
  • 2.4. Forecast Methodology
  • 2.5. Robust Quality Control
  • 2.6. Key Market Segmentations
  • 2.7. Key Considerations
    • 2.7.1. Demographics
    • 2.7.2. Economic Factors
    • 2.7.3. Government Regulations
    • 2.7.4. Supply Chain
    • 2.7.5. COVID Impact / Related Factors
    • 2.7.6. Market Access
    • 2.7.7. Healthcare Policies
    • 2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

  • 3.1. Chapter Overview
  • 3.2. Market Dynamics
    • 3.2.1. Time Period
      • 3.2.1.1. Historical Trends
      • 3.2.1.2. Current and Forecasted Estimates
    • 3.2.2. Currency Coverage
      • 3.2.2.1. Overview of Major Currencies Affecting the Market
      • 3.2.2.2. Impact of Currency Fluctuations on the Industry
    • 3.2.3. Foreign Exchange Impact
      • 3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
      • 3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
    • 3.2.4. Recession
      • 3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
      • 3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
    • 3.2.5. Inflation
      • 3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
      • 3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION

  • 5.1. Chapter Overview
  • 5.2. Concept of Medical Aesthetics
  • 5.3. Evolution of Medical Aesthetics
  • 5.4. Types of Medical Aesthetic Procedures
    • 5.4.1. Non-invasive Procedures
      • 5.4.1.1. Facial Aesthetics
        • 5.4.1.1.1. Botulinum Toxin
        • 5.4.1.1.2. Dermal Fillers
        • 5.4.1.1.3. Chemical Peels
        • 5.4.1.1.4. Microdermabrasion
        • 5.4.1.1.5. Microneedling
        • 5.4.1.1.6. Thread Lift
      • 5.4.1.2. Body Contouring
      • 5.4.1.3. Hair Removal
        • 5.4.1.3.1. Intense Pulse Light Hair Removal
        • 5.4.1.3.2. Laser Hair Removal
      • 5.4.1.4. Tattoo Removal
      • 5.4.1.5. Nail Treatment
      • 5.4.1.6. Eyelash Treatment
      • 5.4.1.7. Permanent Make-up
    • 5.4.2. Invasive Procedures
      • 5.4.2.1. Breast Surgery
      • 5.4.2.2. Gluteal Implants
      • 5.4.2.3. Facial Surgery
      • 5.4.2.4. Liposuction
      • 5.4.2.5. Cosmetic Gynecology
  • 5.5. Advantages of Medical Aesthetics
  • 5.6. Side Effects of Medical Aesthetics
  • 5.7. Key Growth Drivers
  • 5.8. Emerging Technologies in Medical Aesthetics
    • 5.8.1. Virtual Reality in Medical Aesthetics
    • 5.8.2. Augmented Reality in Medical Aesthetics
    • 5.8.3. Artificial Intelligence in Medical Aesthetics
    • 5.8.4. Telemedicine in Medical Aesthetics
  • 5.9. Key Challenges of Medical Aesthetics
  • 5.10. Future Perspectives

6. MARKET LANDSCAPE

  • 6.1. Chapter Overview
  • 6.2. Medical Aesthetic Companies: Overall Market Landscape
    • 6.2.1. Analysis by Year of Establishment
    • 6.2.2. Analysis by Company Size
    • 6.2.3. Analysis by Location of Headquarters (Region)
    • 6.2.4. Analysis by Location of Headquarters (Country)
    • 6.2.5. Analysis by Year of Establishment and Location of Headquarters (Region)
    • 6.2.6. Analysis by Company Size and Location of Headquarters (Region)
    • 6.2.7. Analysis by Type of Offering
    • 6.2.8. Analysis by Type of Products and / or Devices Offered
    • 6.2.9. Analysis by Type of Facial Aesthetic Products and / or Devices Offered
    • 6.2.10. Analysis by Type of Body Contouring Products and / or Devices Offered
    • 6.2.11. Analysis by Type of Hair Removal Devices Offered
    • 6.2.12. Analysis by Type of Breast Aesthetic Products and / or Devices Offered
    • 6.2.13. Analysis by Application Area
    • 6.2.14. Analysis by Type of Procedure
    • 6.2.15. Analysis by End-user
    • 6.2.16. Analysis by Type of Products and / or Devices Offered and Location of Headquarters (Region)
    • 6.2.17. Analysis by Type of Procedure and Location of Headquarters (Region)

7. COMPANY PROFILES

  • 7.1. Chapter Overview
  • 7.2. Detailed Company Profiles of Key Players
    • 7.2.1. Companies Headquartered in North America
      • 7.2.1.1. Allergan Aesthetics
        • 7.2.1.1.1. Company Overview
        • 7.2.1.1.2. Financial Information
        • 7.2.1.1.3. Medical Aesthetics Portfolio
        • 7.2.1.1.4. Recent Developments and Future Outlook
      • 7.2.1.2. Candela Medical
        • 7.2.1.2.1. Company Overview
        • 7.2.1.2.2. Medical Aesthetics Portfolio
        • 7.2.1.2.3. Recent Developments and Future Outlook
      • 7.2.1.3. Cynosure
        • 7.2.1.3.1. Company Overview
        • 7.2.1.3.2. Medical Aesthetics Portfolio
        • 7.2.1.3.3. Recent Developments and Future Outlook
      • 7.2.1.4. Lutronic
        • 7.2.1.4.1. Company Overview
        • 7.2.1.4.2. Medical Aesthetics Portfolio
        • 7.2.1.4.3. Recent Developments and Future Outlook
      • 7.2.1.5. Mentor
        • 7.2.1.5.1. Company Overview
        • 7.2.1.5.2. Medical Aesthetics Portfolio
        • 7.2.1.5.3. Recent Developments and Future Outlook
    • 7.2.2. Companies Headquartered in Europe
      • 7.2.2.1. BTL Aesthetics
        • 7.2.2.1.1. Company Overview
        • 7.2.2.1.2. Medical Aesthetics Portfolio
        • 7.2.2.1.3. Recent Developments and Future Outlook
      • 7.2.2.2. Croma Pharma
        • 7.2.2.2.1. Company Overview
        • 7.2.2.2.2. Financial Information
        • 7.2.2.2.3. Medical Aesthetics Portfolio
        • 7.2.2.2.4. Recent Developments and Future Outlook
      • 7.2.2.3. Galderma
        • 7.2.2.3.1. Company Overview
        • 7.2.2.3.2. Financial Information
        • 7.2.2.3.3. Medical Aesthetics Portfolio
        • 7.2.2.3.4. Recent Developments and Future Outlook
      • 7.2.2.4. IBSA
        • 7.2.2.4.1. Company Overview
        • 7.2.2.4.2. Medical Aesthetics Portfolio
        • 7.2.2.4.3. Recent Developments and Future Outlook
      • 7.2.2.5. Sinclair Pharma
        • 7.2.2.5.1. Company Overview
        • 7.2.2.5.2. Medical Aesthetics Portfolio
        • 7.2.2.5.3. Recent Developments and Future Outlook
    • 7.2.3. Companies Headquartered in Asia-Pacific and Rest of the World
      • 7.2.3.1. Classys
        • 7.2.3.1.1. Company Overview
        • 7.2.3.1.2. Financial Information
        • 7.2.3.1.3. Medical Aesthetics Portfolio
        • 7.2.3.1.4. Recent Developments and Future Outlook
      • 7.2.3.2. Daeyang Medical
        • 7.2.3.2.1. Company Overview
        • 7.2.3.2.2. Medical Aesthetics Portfolio
        • 7.2.3.2.3. Recent Developments and Future Outlook
      • 7.2.3.3. Establishment Labs
        • 7.2.3.3.1. Company Overview
        • 7.2.3.3.2. Financial Information
        • 7.2.3.3.3. Medical Aesthetics Portfolio
        • 7.2.3.3.4. Recent Developments and Future Outlook
      • 7.2.3.4. Lumenis
        • 7.2.3.4.1. Company Overview
        • 7.2.3.4.2. Medical Aesthetics Portfolio
        • 7.2.3.4.3. Recent Developments and Future Outlook
      • 7.2.3.5. Shanghai Haohai Biological Technology
        • 7.2.3.5.1. Company Overview
        • 7.2.3.5.2. Financial Information
        • 7.2.3.5.3. Medical Aesthetics Portfolio
        • 7.2.3.5.4. Recent Developments and Future Outlook
  • 7.3. Short Profiles of Other Prominent Players
    • 7.3.1. ADSS
      • 7.3.1.1. Company Overview
      • 7.3.1.2. Medical Aesthetics Portfolio
    • 7.3.2. Astiland
      • 7.3.2.1. Company Overview
      • 7.3.2.2. Medical Aesthetics Portfolio
    • 7.3.3. Beijing Kes Biological Technology
      • 7.3.3.1. Company Overview
      • 7.3.3.2. Medical Aesthetics Portfolio
    • 7.3.4. Guangzhou Itech Aesthetics 7.3.4.1.Company Overview
      • 7.3.4.2. Medical Aesthetics Portfolio
    • 7.3.5. MedicalZone
      • 7.3.5.1. Company Overview
      • 7.3.5.2. Medical Aesthetics Portfolio
    • 7.3.6. Sanhe Medical
      • 7.3.6.1. Company Overview
      • 7.3.6.2. Medical Aesthetics Portfolio
    • 7.3.7. Sincoheren
      • 7.3.7.1. Company Overview
      • 7.3.7.2. Medical Aesthetics Portfolio
    • 7.3.8. Skin Tech Pharma
      • 7.3.8.1. Company Overview
      • 7.3.8.2. Medical Aesthetics Portfolio
    • 7.3.9. Wontech
      • 7.3.9.1. Company Overview
      • 7.3.9.2. Medical Aesthetics Portfolio
    • 7.3.10. Zesay Beauty
      • 7.3.10.1. Company Overview
      • 7.3.10.2. Medical Aesthetics Portfolio

8. COMPANY COMPETITIVENESS ANALYSIS

  • 8.1. Chapter Overview
  • 8.2. Key Assumptions and Parameters
  • 8.3. Methodology
  • 8.4. Medical Aesthetics: Company Competitiveness Analysis
    • 8.4.1. Companies based in North America
    • 8.4.2. Companies based in Europe
    • 8.4.3 Companies based in Asia-Pacific and Rest of the World

9. PARTNERSHIPS AND COLLABORATIONS

  • 9.1. Chapter Overview
  • 9.2. Partnership Models
  • 9.3. Medical Aesthetics: Partnerships and Collaborations
    • 9.3.1. Analysis by Year of Partnership
    • 9.3.2. Analysis by Type of Partnership
    • 9.3.3. Analysis by Year and Type of Partnership
    • 9.3.4. Analysis by Focus Area
    • 9.3.5. Most Active Players: Analysis by Number of Partnerships
  • 9.4. Analysis by Geography
    • 9.4.1. Local and International Agreements
    • 9.4.2. Intracontinental and Intercontinental Agreements

10. FUNDING AND INVESTMENTS

  • 10.1. Chapter Overview
  • 10.2. Funding Models
  • 10.3. Medical Aesthetics: Funding and Investments
    • 10.3.1. Analysis by Year of Funding
    • 10.3.2. Analysis by Amount Invested
    • 10.3.3. Analysis by Type of Funding
    • 10.3.4. Analysis by Year and Type of Funding
    • 10.3.5. Analysis by Type of Funding and Amount Invested
    • 10.3.6. Analysis by Geography
    • 10.3.7. Most Active Players
      • 10.3.7.1. Analysis by Number of Funding Instances
      • 10.3.7.2. Analysis by Amount Raised
    • 10.3.8. Leading Investors: Analysis by Number of Funding Instances
    • 10.3.9. Analysis by Company Size and Amount Invested
  • 10.4. Concluding Remarks

11. DELT ANALYSIS

  • 11.1. Chapter Overview
  • 11.2. Methodology
  • 11.3. Key Parameters
    • 11.3.1. Demographical Factors
    • 11.3.2. Environmental Factors
    • 11.3.3. Legal Factors
    • 11.3.4. Technological Factors
  • 11.4. Medical Aesthetics: DELT Analysis
    • 11.4.1. Allergan Aesthetics
    • 11.4.2. Candela
    • 11.4.3. Cutera
    • 11.4.4. Biotechitalia
    • 11.4.5. Sinclair Pharma
    • 11.4.6. Merz Pharma
    • 11.4.7. Dermosistemi
    • 11.4.8. Alma Lasers
    • 11.4.9. Bison Medical
  • 11.5. Conclusion

12. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

  • 12.1. Chapter Overview
  • 12.2. Market Drivers
  • 12.3. Market Restraints
  • 12.4. Market Opportunities
  • 12.5. Market Challenges
  • 12.6. Conclusion

13. GLOBAL MEDICAL AESTHETICS MARKET

  • 13.1. Chapter Overview
  • 13.2. Key Assumptions and Methodology
  • 13.3. Global Medical Aesthetics Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 13.3.1. Scenario Analysis
      • 13.3.1.1. Conservative Scenario Analysis
      • 13.3.1.2. Optimistic Scenario Analysis
  • 13.4. Key Market Segmentations
  • 13.5. Dynamic Dashboards

14. MEDICAL AESTHETICS MARKET, BY TYPE OF PRODUCT AND / OR DEVICE OFFERED

  • 14.1. Chapter Overview
  • 14.2. Key Assumptions and Methodology
  • 14.3. Medical Aesthetics Market: Distribution by Type of Product and / or Device Offered, 2018, 2023 and 2035
    • 14.3.1. Botox: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 14.3.2. Dermal Fillers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 14.3.3. Chemical Peels: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 14.3.4. Body Contouring: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 14.3.5. Hair Removal: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 14.3.6. Breast Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 14.3.7. Gluteal Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 14.3.8. Other Products and / or Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 14.4. Data Triangulation and Validation

15. MEDICAL AESTHETICS MARKET, BY TYPE OF PROCEDURE

  • 15.1. Chapter Overview
  • 15.2. Key Assumptions and Methodology
  • 15.3. Medical Aesthetics Market: Distribution by Type of Procedure, 2018, 2023 and 2035
    • 15.3.1. Non-invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 15.3.2. Minimally Invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 15.3.3. Invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 15.4. Data Triangulation and Validation

16. MEDICAL AESTHETICS MARKET, BY END-USER

  • 16.1. Chapter Overview
  • 16.2. Key Assumptions and Methodology
  • 16.3. Medical Aesthetics Market: Distribution by End-user, 2018, 2023 and 2035
    • 16.3.1. Hospitals: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

16.3.2.. Clinics / Med Spas and Dermatology / Cosmetology Centers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

    • 16.3.3. Other End-users: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 16.4. Data Triangulation and Validation

17. MEDICAL AESTHETICS MARKET, BY GENDER

  • 17.1. Chapter Overview
  • 17.2. Key Assumptions and Methodology
  • 17.3. Medical Aesthetics Market: Distribution by Gender, 2018, 2023 and 2035
    • 17.3.1. Females: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 17.3.2. Males: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 17.4. Data Triangulation and Validation

18. MEDICAL AESTHETICS MARKET, BY DISTRIBUTION CHANNEL

  • 18.1. Chapter Overview
  • 18.2. Key Assumptions and Methodology
  • 18.3. Medical Aesthetics Market, by Distribution Channel, 2018, 2023 and 2035
    • 18.3.1. Direct Distribution: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 18.3.2. Indirect Distribution: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 18.4. Data Triangulation and Validation

19. MEDICAL AESTEHTICS MARKET, BY KEY GEOGRAPHICAL REGION

  • 19.1. Chapter Overview
  • 19.2. Key Assumptions and Methodology
  • 19.3. Medical Aesthetics Market: Distribution by Key Geographical Regions, 2019, 2023 and 2035
    • 19.3.1. North America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.1.1. US: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.1.2. Canada: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.1.3. Mexico: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
    • 19.3.2. Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.2.1. UK: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.2.2. Germany: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.2.3. France: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.2.4. Italy: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.2.5. Spain: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.2.5. Rest of the Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
    • 19.3.3. Asia-Pacific: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.3.1. China: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.3.2. South Korea Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.3.3. Japan: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.3.4. India: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
    • 19.3.4. Middle East and North Africa: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.4.1. Turkey: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.4.2. Iran: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.4.3. Rest of the Middle East and North Africa: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
    • 19.3.5. Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.5.1. Brazil: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.5.2. Argentina: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.5.3. Rest of the Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 19.4. Data Triangulation and Validation

20. MEDICAL AESTHETICS PRODUCTS MARKET

  • 20.1. Chapter Overview
  • 20.2. Key Assumptions and Methodology
  • 20.3. Global Medical Aesthetics Products Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 20.3.1. Medical Aesthetics Products Market, by Type of Product Offered, 2018, 2023 and 2035
      • 20.3.1.1. Botox: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 20.3.1.2. Dermal Fillers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 20.3.1.3. Chemical Peels: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 20.3.1.4. Breast Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 20.3.1.5. Gluteal Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 20.4.1. Medical Aesthetics Products Market, by Key Geographical Regions, 2018, 2023 and 2035
      • 20.4.1.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 20.4.1.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 20.4.1.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 20.4.1.4. Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 20.4.1.5. Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 20.5. Data Triangulation and Validation

21. EXECUTIVE INSIGHTS

22. CONCLUSION

23. APPENDIX 1: TABULATED DATA

24. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS